- Home
- ALHC
as 04-18-2025 1:30pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 3.1B | IPO Year: | 2021 |
| Target Price: | $16.95 | AVG Volume (30 days): | 3.5M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.71 - $21.06 | Next Earning Date: | 05-01-2025 |
| Revenue: | $2,703,561,000 | Revenue Growth: | 48.25% |
| Revenue Growth (this year): | 41.44% | Revenue Growth (next year): | 24.84% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| KAO JOHN E | ALHC | Chief Executive Officer | Apr 14 '25 | Sell | $19.10 | 90,000 | $1,718,721.00 | 2,003,100 | |
| Maroney Dawn Christine | ALHC | President | Apr 14 '25 | Sell | $19.10 | 230,000 | $4,392,195.00 | 2,132,899 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Apr 1 '25 | Sell | $18.47 | 25,000 | $461,632.50 | 415,022 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 27 '25 | Sell | $17.89 | 2,864 | $51,236.96 | 702,953 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Mar 27 '25 | Sell | $17.89 | 34,430 | $615,952.70 | 2,003,100 | |
| Kardes Hakan | ALHC | Chief Experience Officer | Mar 27 '25 | Sell | $17.89 | 7,225 | $129,255.25 | 678,987 | |
| Maroney Dawn Christine | ALHC | President | Mar 27 '25 | Sell | $17.89 | 11,152 | $199,509.28 | 2,132,899 | |
| Kim Hyong | ALHC | Chief Medical Officer | Mar 20 '25 | Sell | $17.22 | 26,734 | $460,300.67 | 509,367 | |
| Kim Hyong | ALHC | Chief Medical Officer | Mar 19 '25 | Sell | $16.52 | 8,266 | $135,570.55 | 509,367 | |
| Burzacchi Sebastian | ALHC | COO - Mgmt Services Org | Mar 19 '25 | Sell | $16.52 | 6,694 | $109,788.22 | 252,784 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Alignment Healthcare And 2 Other Stocks That Might Be Priced Below Their Fair Value
Zacks
4 days ago
Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?
GlobeNewswire
4 days ago
Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments
GlobeNewswire
8 days ago
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
Simply Wall St.
8 days ago
Should You Think About Buying Alignment Healthcare, Inc. (NASDAQ:ALHC) Now?
StockStory
9 days ago
Health Insurance Providers Stocks Q4 Teardown: Humana (NYSE:HUM) Vs The Rest
Insider Monkey
10 days ago
Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday?
Zacks
10 days ago
Alignment Healthcare (ALHC) Surges 6.3%: Is This an Indication of Further Gains?
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.